Technology Team

• ▸PhD, Nova Southeastern University (NSU) — Specialization in information security policy design in exceptional circumstances
• ▸MS, Management Information Systems (Information Security), Nova Southeastern University
• ▸BS, Computer Science and Telecommunications, SUNY Polytechnic Institute

• ▸Certified Information Security Manager (CISM)

• ◆United States Patent and Trademark Office, 2020, U.S. Patent No. 10,673,617 — "Methods, System and Point-to-Point Encryption Device Microchip for AES-SEA 512-Bit Key Using Identity Access Management Utilizing Blockchain Ecosystem to Improve Cybersecurity"

• ◆Antoniou, G. (2018, Spring-Summer). [Review of the book InSecurity, by J. Frankland]. Journal of Multidisciplinary Research, 10(1-2), 203-204.
• ◆Antoniou, G. (2018). A framework for the governance of information security: Can it be used in an organization. Poster presented at: IEEE SoutheastCon 2018; 2018 Apr 19-22; St. Petersburg, FL

Dr. Antoniou is currently an Associate Professor of Cybersecurity Management at Lynn University. Prior to this, he served as an Assistant Professor at St. Thomas University and held various leadership positions in information security at Fortune 500 corporations, including:

• ▸Director of Information Security — Providing leadership, vision, and direction for information security policies and programs
• ▸Global Group Director of Information Security — Advising executive officers on information security risks and implementing global security programs
• ▸Senior Information Security Manager — Managing encryption technologies, security compliance, and risk assessment

At Biomolecular LLC, Dr. Antoniou leads our data science initiatives, ensuring secure and compliant management of sensitive research data. His expertise in blockchain technology and cybersecurity provides a critical foundation for our innovative approach to biomedical research and development.

• ▸BS in Electrical Engineering, Institute Superior Polytechnic "Jose A. Echeverria", Havana, Cuba (1984–1989)
• ▸Equivalent BSEL in Electrical Engineering (Josef Silny & Associates Inc, International Education Consultants)

• ▸Embedded systems design and development
• ▸Microchip design and implementation
• ▸Electrical schematic design and PCB architecture
• ▸Software development for medical devices
• ▸Real-time system programming
• ▸Biomedical technology engineering

• ◆United States Patent and Trademark Office, 2020, U.S. Patent No. 10,673,617 — "Methods, System and Point-to-Point Encryption Device Microchip for AES-SEA 512-Bit Key Using Identity Access Management Utilizing Blockchain Ecosystem to Improve Cybersecurity"
• ◆Developer of Medical Device – Electric Stimulator — U.S. Patent No. 8,457,745 B1, June 04, 2013

• ◆Co-author: "The Cure for Diabetes Type 2 (And how we discovered it)"
• ◆"Integration of AI, Innovative Electromagnetic Stimulation and Reverberatory Circuitry in Diabetes Treatment," Spectrum Conferences & Expos, Valencia, Spain, August 2024

Roberto is an accomplished firmware and embedded systems developer with extensive experience in hardware and software engineering. His career spans multiple organizations where he has developed cutting-edge technologies:

• ▸Senior Hardware Engineer at PIXEL on Target (2024–2025)
• ▸Senior Firmware Electrical Engineer at FK Irons (2019–2024)
• ▸Senior Developer Engineer at Neurotronix Enterprises Inc. (2007–2019)
• ▸Radio Frequency and Software Developer Engineer at NCM Supplies Inc. (2004–2007)
• ▸Firmware/Hardware Engineer at Aspen Electronics (2003–2004)
• ▸Developer Engineer at Gamma Technology (2000–2003)
• ▸Developer Engineer at Practical Device (1999–2000)
• ▸Engineer for neurosurgical medical equipment at Micromar, Sao Paulo (1995–1999)
• ▸Biomedical Engineer at International Center of Restoration Neurology (1993–1996)
• ▸Researcher at Academic Science of Cuba (1989–1996)

At Biomolecular LLC, Roberto leads the engineering team responsible for developing microchips, system designs, electrical schematics, and software for our biomedical technology initiatives. His extensive experience in neurostimulation systems and medical device engineering provides crucial technical expertise for our innovative healthcare solutions, particularly in diabetes treatment technologies.